Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer gives details on the discovery of novel noncovalent modulator of hemoglobin

Dec. 11, 2019

Anti-BCMA CAR-T candidate C-CAR088 shows early clinical efficacy

Dec. 11, 2019

Implicit Bioscience presents phase I data for IC-14 in motor neuron disease

Dec. 11, 2019

Intrathecal AVXS-301 shows promise in preclinical models of ALS

Dec. 11, 2019

FDA clears IND application for first-in-human study of CPT-31

Dec. 11, 2019

IND for HLX-10 plus HLX-07 antibody combination therapy approved in China

Dec. 11, 2019

Scohia Pharma initiates phase I study of SCO-267

Dec. 11, 2019

CARsgen Therapeutics receives IND clearance for AB-011 in China

Dec. 11, 2019

Enterovirus contributes to islet autoimmunity

Dec. 11, 2019

Killer T cells protected by membrane lipid order and charge

Dec. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...